Immunostaining and flow cytometry revealed that the nuclear Notch1 ICD and Hey1 levels, respectively, were enhanced in the GIT1 knockdown tumours compared to the control tumours (Fig. 5h–j). This evidence concerns the gene NOTCH1 and neoplasm.